Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells

This publication has 27 references indexed in Scilit:

• Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all‐trans retinoic acid
  British Journal of Haematology, 2000
• The language of covalent histone modifications
  Nature, 2000
• FR901228, a Potent Antitumor Antibiotic, Is a Novel Histone Deacetylase Inhibitor
  Experimental Cell Research, 1998
• Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL
  Nature Genetics, 1998
• Histone Deacetylase Inhibitor Activates the WAF1/Cip1 Gene Promoter through the Sp1 Sites
  Biochemical and Biophysical Research Communications, 1997
• Histone Deacetylase: A Regulator of Transcription
  Science, 1996
• Trichostatin A Induces Morphological Changes and Gelsolin Expression by Inhibiting Histone Deacetylase in Human Carcinoma Cell Lines
  Experimental Cell Research, 1994
• FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice.
  The Journal of Antibiotics, 1994
• FR901228, a novel antitumor bicyclic depsipeptide produced by chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity.
  The Journal of Antibiotics, 1994
• Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells
  Cell, 1991